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Background: Recent clinical, experimental and modeling studies link oscillations of
ventricular repolarization in the low frequency (LF) (approx. 0.1 Hz) to arrhythmogenesis.
Sympathetic provocation has been shown to enhance both LF oscillations of action
potential duration (APD) and beat-to-beat variability (BVR) in humans. We hypothesized
that beta-adrenergic blockade would reduce LF oscillations of APD and BVR of APD in
humans and that the two processes might be linked.
Methods and Results: Twelve patients with normal ventricles were studied during
routine electrophysiological procedures. Activation-recovery intervals (ARI) as a
conventional surrogate for APD were recorded from 10 left and 10 right ventricular
endocardial sites before and after acute beta-adrenergic adrenergic blockade. Cycle
length was maintained constant with right ventricular pacing. Oscillatory behavior of
ARI was quantified by spectral analysis and BVR as the short-term variability. Beta-
adrenergic blockade reduced LF ARI oscillations (8.6 ± 4.5 ms2 vs. 5.5 ± 3.5 ms2,
p = 0.027). A significant correlation was present between the initial control values and
reduction seen following beta-adrenergic blockade in LF ARI (rs = 0.62, p = 0.037)
such that when initial values are high the effect is greater. A similar relationship was also
seen in the beat-to beat variability of ARI (rs = 0.74, p = 0.008). There was a significant
correlation between the beta-adrenergic blockade induced reduction in LF power of
ARI and the witnessed reduction of beat-to-beat variability of ARI (rs = 0.74, p = 0.01).
These clinical results accord with recent computational modeling studies which provide
mechanistic insight into the interactions of LF oscillations and beat-to-beat variability of
APD at the cellular level.
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Conclusion: Beta-adrenergic blockade reduces LF oscillatory behavior of APD (ARI) in
humans in vivo. Our results support the importance of LF oscillations in modulating the
response of BVR to beta-adrenergic blockers, suggesting that LF oscillations may play
role in modulating beta-adrenergic mechanisms underlying BVR.
Keywords: action potential duration, beat-to-beat variability, oscillations, human heart, sympathetic, beta-
adrenergic blockade
INTRODUCTION
Factors which influence the stability of ventricular repolarization
are important in arrhythmogenesis. Enhanced oscillation
of ventricular repolarization in the low frequency range
and increased beat-to-beat variability (BVR) of ventricular
repolarization are two of the strongest predictors of arrhythmia
and sudden cardiac death (Atiga et al., 1998; Haigney et al., 2004;
Thomsen et al., 2004; Gallacher et al., 2007; Tereshchenko et al.,
2009; Abi-Gerges et al., 2010; Hinterseer et al., 2010; Jacobson
et al., 2011; Średniawa et al., 2012; Rizas et al., 2014, 2016, 2017;
Baumert et al., 2016; Bauer et al., 2019). Both are enhanced by
sympathetic stimulation and recent studies suggest a possible
interactive mechanism (Porter et al., 2018). However, the
mechanisms underlying the effect of beta-adrenergic stimulation
on LF oscillations of repolarization and beat-to-beat variability
of repolarization remain unclear.
Oscillations of ventricular repolarization measured from
the ECG T-wave vector referred to as periodic repolarisation
dynamics (PRD) have been attributed to oscillations in APD
at the frequency of the sympathetic nerves (approx. 0.05–
0.1 Hz). Ventricular action potential duration (APD) measured
as activation-recovery intervals (ARI) has recently been shown
to oscillate in this frequency range (Hanson et al., 2014). The LF
power of APD has been shown to be increased by sympathetic
provocation (Porter et al., 2018). The recent finding of LF
oscillations in short term variability of ventricular APD (Porter
et al., 2018) raises the possibility of an association between LF
oscillations of APD and BVR.
Computational modeling has provided early insight into the
mechanisms underlying these oscillations of APD, the effect
of beta-adrenergic stimulation and their relationship to the
initiation of ventricular arrhythmias (Pueyo et al., 2016a,b). More
recent studies on the effect of beta-adrenergic blockade suggest
that the cellular mechanisms underlying modulation of LF APD
and BVR of APD are strongly influenced by the initial conditions
of APD (Sampedro-Puente et al., 2019). One of the objectives
of the present study was to examine this hypothesis in humans
in vivo.
We have studied 12 patients during cardiac catheterization
allowing us to measure ARIs as an approximation for APD at 10
right ventricular (RV) and 10 left ventricular (LV) endocardial
sites in order to investigate the effect of acute beta-adrenergic
blockade on LF oscillations of ventricular APD and on BVR of
APD, and the possible interaction between the two. Cycle length
was held constant with RV pacing to avoid confounding effects
due to the cycle length dependency of APD.
MATERIALS AND METHODS
Ethical Approval
The study was approved by the Ethics Committee of Guy’s
and Thomas’ Hospitals and conformed to the standards set
by the Declaration of Helsinki (latest revision: 59th World
Medical Association General Assembly). All patients gave
written, informed consent.
Subjects
Studies were performed in 12 patients (10 males, 2 females,
aged 41–69, median 61) during the course of routine clinical
radiofrequency ablation procedures for atrial fibrillation. Four
patients had paroxysmal atrial fibrillation, and eight patients
had persistent atrial fibrillation. All subjects had normal
biventricular systolic function. Table 1 demonstrates further
patient characteristics. Studies were performed in the un-
sedated state and cardio-active medications (beta-blockers,
non-dihydropyridine calcium channel blockers, digoxin, and
flecainide) were discontinued for 5 days before the study.
Protocol
Utilizsing the routine transseptal puncture of an AF ablation,
a decapolar catheter was placed in the left ventricle via the
left atrium and mitral valve. The pacing catheter and second
decapolar catheter were placed in the right ventricle. Routine
AF ablation femoral venous access was utilized for placement
of all catheters. The transseptal puncture was conducted under
radiographic guidance. Figure 1A shows the set-up of both
recording decapolar catheters and the pacing catheter. Subjects
were paced from the right ventricular apex using a Biotronik
(Berlin, Germany) stimulator (model UHS 3000) at 2x diastolic
TABLE 1 | Patient characteristics.
Diabetes 2 (17%)
Sleep apnoea 0 (0%)
Hypertension 5 (42%)
Left atrial diameter 4.2±0.4 cm
Presence of left ventricular hypertrophy 2 (17%)
Presence of diastolic dysfunction 2 (17%)
Beta-blocker 7 (60%)
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FIGURE 1 | Diagram of (A) decapolar catheter electrodes in RV and LV and pacing wire and (B) the schematic illustration of relation between the activation recovery
interval (ARI) in the unipolar EGM and the ventricular action potential duration (APD).
threshold and 2 ms pulse width, at a cycle length >20 beats/min
faster than the intrinsic AF rate (median: 500 ms; range: 360–
500 ms) to avoid breakthrough of intrinsic beats. A 2-min
period of adaptation to the paced cycle length was applied before
starting a controlled breathing protocol. Breathing was controlled
throughout the protocol at 0.25 and 0.5 Hz. Recordings took place
for 90s during each controlled breathing cycle. First, a control
period was established with the breathing protocol performed
in absence of any autonomic blocking agents. Pacing was then
stopped and the subject received metoprolol at a dose sufficient
to reduce the intrinsic heart rate by 10 beats/min (iv; dose range,
2–10 mg), and after a further 10 min for equilibration the pacing
(at the same paced cycle length as the control) and breathing
protocol was repeated as above. The entire study protocol was
completed prior to conducting the AF ablation.
Measurements
Continuous synchronous recordings of femoral arterial blood
pressure and unipolar electrograms (UEGs) at 10 endocardial
RV and 10 endocardial LV sites (Figure 1A) were obtained
before routine clinical radiofrequency ablation procedures for
atrial fibrillation in the cardiac catheterization lab at St Thomas’
Hospital in London, as described previously (Hanson et al.,
2012; van Duijvenboden et al., 2015). UEGs and blood pressure
recordings were digitized at 1,200 Hz (Ensite 3000; Endocardial
Solutions) and analyzed offline.
Data Analysis
UEGs were analyzed for ventricular APDs at each recording
site by measuring activation-recovery intervals (ARIs) using
the Wyatt method (Wyatt et al., 1981). This method has been
validated in theoretical, computational, and experimental studies
(Wyatt et al., 1981; Haws and Lux, 1990; Coronel et al., 2006;
Potse et al., 2009). According to this method, activation is
measured at the moment of minimum dV/dt of the QRS complex
of the UEG and repolarization at the moment of maximum dV/dt
of the T-wave (Figure 1B). ARIs were measured automatically
using in house developed algorithms. Heuristic-based screening
was used to identify and discount any cases where the T-wave was
indistinct or corrupt. Blood pressure recordings were analyzed
for systolic blood pressure (SBP) and the maximum rate of
systolic pressure increase (dP/dtmax) as a measure of myocardial
contractility. Measurement of dP/dtmax from the femoral artery
has been shown to provide good tracking of left ventricular
contractility (Monge Garcia et al., 2018).
To establish evenly sampled series, any beats for which ARI,
SBP or dP/dtmax measurements could not be determined were
replaced by linear interpolation between the surrounding beats.
Recordings were rejected from the analysis if these surrogate
beats constituted more than 10% of any series.
The low frequency (LF) power in each ARI series was
estimated by calculating the bandpower in the low-frequency
band (0.04–0.15 Hz) using the Thomson’s multitaper method
with three Slepian tapers, which is known to be robust against
noise (Thomson, 1982). The same analysis was applied to the
calculate the high frequency (HF) power in in a frequency band
of the breathing frequency (either 0.25 or 0.5 Hz)± 10%. The LF
and HF powers were then averaged for RV and LV poles.
Beat-to-beat variability of ARI was assessed by computing
the short term variability (STV) of ARIs for each endocardial
recording site over the entire recording as per established STV
measures (Johnson et al., 2013; Baumert et al., 2016). The STV








where ARIi is the ARI at the ith beat and N is the number of beats.
For each pole, we computed the mean STV in time and then
averaged these values across poles. The STV of SBP (STV-SBP)
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and dP/dtmax (STV-dP/dtmax) were computed using the same
formula and number of beats as for ARI.
Statistical Analysis
Results were averaged across the two separate breathing cycles
for both control recordings and following introduction of beta-
adrenergic blockade. Results are presented as mean ± standard
deviation for normally distributed variables and as median and
interquartile range (IQR) for non-normally distributed variables.
The effect of beta-adrenergic blockade on LF power for ARI, SBP
and dP/dtmax was tested for statistical significance using the two-
tailed paired Wilcoxon signed–rank test. To evaluate whether
there were different responses in ARI STV between individual
electrodes (n = 20), we used the non-parametric Kruskal–Wallis
test. Results were considered significant at p < 0.05.
RESULTS
Effect of Beta-Adrenergic Blockade on
Combined Group Data
Example ARI, SBP and dP/dtmax time series of one patient
breathing at 15 breaths/min (0.25 Hz) during control and
following beta-adrenergic blockade are shown in Figure 2.
In this example, clear LF oscillations are visible in all traces
during control. which are attenuated following beta-adrenergic
blockade. At the same time, there is a clear reduction in the STV.
In the group data, beta-adrenergic blockade resulted in a
significant reduction of LF power of ARI (8.6 ± 4.5 ms2
vs. 5.5 ± 3.5 ms2, p = 0.027) (Figure 3A) and the LF
power of SBP (1.4 × 10−3 ± 1.2 × 10−3 mmHg2 vs.
0.4 × 10−3 ± 0.5 × 10−3 mmHg2, p = 0.027) (Figure 3B).
A trend to reduction was observed for the LF power of dP/dtmax
(0.7× 10−6 ± 1× 10−6 vs. 0.1× 10−6 ± 0.2× 10−6 mmHg2/s2,
p = 0.129) (Figure 3C).
No effect of beta-adrenergic blockade was seen on
the HF power of ARI (6.5 × 10−3 ± 3 × 10−3 ms2
vs. 6.1 × 10−3 ± 3.4 × 10−3 ms2, p = 0.91),
SBP (1.9 × 10−3 ± 1 × 10−3 mmHg2 vs.
1.7 × 10−3 ± 1 × 10−3 mmHg2, p = 0.424), nor dP/dtmax
(7.6 × 10−7 ± 7.4 × 10−7 mmHg2/s2 vs. 3.2 ± 3.9 mmHg2/s2,
p = 0.052).
No immediate effect of beta-adrenergic blockade was seen on
mean ARI for group data (186.9 ± 22.8 vs. 186.5 ± 20.5 ms,
p = 0.4) or the beat-to-beat variability (STV-ARI: 4.26 ± 1.3
vs. 4.03 ± 0.96 ms, p = 0.97). We also did not observe
an effect on the beat-to-beat variability of SBP (STV-SBP:
5.52 ± 2.25 vs. 4.75 ± 2.68 mmHg, p = 0.380), but the STV
dP/dtmax was significantly reduced (STV-dP/dtmax 166 ± 102 vs.
102± 80 mmHg/s, p = 0.005).
The ARI STV response to beta-adrenergic blockade was
not different across breathing frequencies: mean ARI STV
reduction −0.1 (±0.7) for 15 breaths/min versus 0.2 (±1.4)
ms for 30 breaths/min, p = 0.8. Furthermore, as shown
in Figure 4, there were no significant differences in ARI
STV reduction between electrode sites in the RV and LV
(p = 0.87 and p = 0.56 for RV and LV, respectively). We also
tested the differences in STV baseline and reduction between
RV and LV. Mean values of STV baseline and reduction
were slightly higher in the LV, but the differences were not
FIGURE 2 | Example ARI, SBP and dP/dtmax time series of one patient breathing at 15 breaths/min (0.25 Hz) during control and following beta-adrenergic blockade.
Clear low-frequency oscillations are visible in all traces during control, which are attenuated following beta-adrenergic blockade. Also note the reduction in the short
time variability (STV) measures. PSD, power spectral density.
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FIGURE 3 | Effect of beta-adrenergic blockade on the low frequency (LF) power (top) and short-term variability (STV) (bottom) of (A) activation-recovery intervals
(ARIs), (B) systolic blood pressure (SBP) and (C) the maximum rate of systolic pressure increase (dP/dtmax).
FIGURE 4 | Reduction of ARI short-time variability (STV) following beta-blocker from individual electrodes in the right and left ventricle (RV and LV). No significant
changes in STV reduction were found across electrode sites. Outliers are marked by crosses.
statistically significant: mean ARI STV baseline: 8.7 ± 8.1 vs.
9.3 ± 5.0 ms, p = 0.4; mean ARI STV reduction: −0.1 ± 1.8
vs. 0.3 ± 1.0, p = 0.1, for RV and LV, respectively. Finally,
we also investigated whether the LF power and STV response
to beta-adrenergic blockade was different in patients who had
previously been treated with beta-blocker (n = 7, Table 1)
compared to those who had not (n = 5). Although medication
was discontinued for 5 days before the study in all patients,
we found that the average response in both ARI LF power
and ARI STV was slightly higher in patients treated with beta-
blockers, but the numbers were too small to allow robust
statistical analysis (mean reduction in LF power: 4.3 ± 5.3 vs.
1.5 ± 1.3 ms2; mean reduction in ARI STV reduction: 0.7 ± 1.5
vs.−0.4± 0.5 ms).
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Influence of Initial Values on the
Response to Beta-Adrenergic Blockade
The effect of beta-adrenergic blockade on the group data was
small. However, a wide range of control values was evident
and when our results were expressed in relation to control
values a highly significant effect of beta-adrenergic blockade was
apparent. Subjects in whom the initial control values of LF of
ARI were large showed a greater change in the magnitude of
the oscillations following beta-adrenergic blockade compared to
subjects in whom the initial values were low. When control
oscillations of ARI were large beta-adrenergic blockade reduced
their magnitude. When control oscillations were small the
response to beta-adrenergic blockade was minimal or variable
(rs = 0.62, p = 0.037) (Figure 5A). A similar relationship was
observed for ARI-STV (rs = 0.74, p = 0.008) (Figure 5B), and the
LF power of SBP and dP/dtmax (rs = 0.78, p = 0.004 and rs = 0.84,
p = 0.001, respectively) (Figures 5C,D).
Relationship Between Low Frequency
Power and Beat-to-Beat Variability of ARI
There was a strong relationship between the reduction in LF
power of ARI and the reduction of STV-ARI in response to beta-
adrenergic blockade (rs = 0.72, p = 0.01) (Figure 6). No significant
relationships were found between the reduction of LF power and
SBP-STV (rs = 0.42, p = 0.2) or dP/dtmax-STV (rs = 0.36, p = 0.3).
There was also no significant relationships between the reduction
in HF power and STV for ARI, SBP, and dP/dtmax: (ARI-STV:
rs = 0.48, p = 0.1. SBP-STV: rs = 0.38, p = 0.3; dP/dtmax –STV:
rs = 0.56, p = 0.06).
DISCUSSION
We studied the effect of acute beta-adrenergic blockade on
LF oscillations of ventricular APD (approximated by ARI)
and on beat-to-beat APD variability. LF power and STV ARI
measurements were made from 10 RV and 10 LV sites and then
averaged in patients with normal ventricles. Cycle length was
maintained constant with right ventricular pacing to eliminate
confounding effects of cycle length dependency and breathing
was controlled throughout the protocol at 0.25 and 0.5 Hz. Our
main findings were: (1) we observed a wide variation of control
values of LF power and beat-to-beat variability of ARI, SBP and
dP/dtmax; (2) beta-adrenergic blockade was associated with a
significant reduction of LF power of ARI and SBP, (3) individually
no clear impact of beta-adrenergic blockade on the beat-to-beat
variability of ARI, SBP and dP/dtmax was demonstrated, however,
(4) there was a strong correlation between the reduction seen
in the LF power of ARI, SBP, and dP/dtmax following beta-
adrenergic blockade, and the reduction in beat-to-beat variability.
Whereas oscillations in heart rate variability have long been
recognized and the underlying mechanisms the subject of much
debate (Parati et al., 2006), oscillations of ventricular APD at
the low frequency have only relatively recently been identified
(Hanson et al., 2014). These LF APD oscillations identified in
FIGURE 5 | Scatterplots demonstrating the significant relationship between baseline values and the reduction seen following beta-adrenergic blockade in: (A) LF
power of ARI, (B) beat-to-beat variability of ARI (STV ARI), (C) LF power of systolic blood pressure (SBP), and (D) the LF power of the maximum rate of systolic
pressure increase (dP/dtmax).
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FIGURE 6 | Scatterplot demonstrating the significant relationship between the
beta-adrenergic blockade induced reduction in the LF power ARI and the
witnessed reduction in beat-to-beat variability of ARI (STV ARI). +, data point.
humans using ARI recordings from the ventricular myocardium,
are independent of variation in R-R interval and independent
of respiration (Hanson et al., 2014). They frequently occur in
association with LF oscillations in blood pressure (Mayer waves)
(Julien, 2006). Oscillation of ventricular repolarization at the low
frequency has recently been identified from the body surface ECG
T-wave vector and these are also independent of R-R interval
variability and respiration and are attributed to LF oscillation
of ventricular APD (Rizas et al., 2014). When enhanced these
oscillations are strongly predictive of arrhythmia and sudden
cardiac death (Rizas et al., 2014, 2016, 2017, 2019; Hamm
et al., 2017). The magnitude of both ARI and T-wave vector
oscillations is increased during sympathetic stimulation (Rizas
et al., 2014; Porter et al., 2017, 2018) and it has been suggested
they may be related to the intrinsic low frequency oscillation of
sympathetic nerve activity.
Enhanced beat-to-beat variability of repolarization, measured
clinically as QT variability or experimentally as APD variability,
is well known to predispose to malignant ventricular arrhythmias
(Atiga et al., 1998; Haigney et al., 2004; Thomsen et al.,
2004; Gallacher et al., 2007; Tereshchenko et al., 2009; Abi-
Gerges et al., 2010; Hinterseer et al., 2010; Jacobson et al.,
2011; Średniawa et al., 2012; Baumert et al., 2016). BVR has
been shown to be enhanced by beta-adrenergic stimulation
(Johnson et al., 2010, 2013; Porter et al., 2017). Paradoxically
studies using beta-adrenergic blockade have shown a mixed
response of BVR in QT interval measurements with either
no change or an increase or decrease (Baumert et al., 2016).
In this work we demonstrate firstly a strong dependence of
the effect of beta blockade on initial conditions, and secondly
a possible interaction between LF power and beat-to-beat
variability of ARI. Importantly, we observed that changes in
beat-to-beat variability were more enhanced following beta-
adrenergic blockade when LF power was reduced. In contrary,
small or no changes were observed in beat-to-beat variability in
individuals for which the LF power was not modulated. Although
these findings may have important mechanistic implications in
this context, it should be noted that beat-to-beat variability
and low frequency power are both measures of variability,
hence the observed relationship between LF power and beat-
to-beat variability could also be a mathematical consequence.
Nevertheless, the results could provide an explanation on the
conflicting results reported on the effect of beta-adrenergic
blockade on beat-to-beat variability. Recently it has also been
observed that the intrinsic beat-to-beat variation in APD also
exhibits phasic variation at the low frequency, which is enhanced
during increased sympathetic stimulation (Porter et al., 2018),
which may further support a possible interaction between LF
ARI and intrinsic beat-to-beat variation in ARI. Interestingly,
preliminary data from this study shows that the response
of LF ARI power and beat-to-beat variability following beta-
adrenergic blockade were more pronounced in individuals
that had previously been treated with beta-blockers. While
the number were too small to draw any final conclusions, it
might highlight a role of the dynamic nature of beta-adrenergic
receptors, but it is also possible that these patients had a
higher sympathetic tone during control. Future work will further
investigate this finding.
The present work was conducted in patients with normal
hearts and we cannot exclude the possibility that the
relationships we observed may have been different in patients
with arrhythmias. However, in this context the following
observations in patients with arrhythmias are worth mention.
In a recent study in heart failure patients ARI recordings as
a measure of local action potential duration were obtained
from the left ventricular epicardial lead of an implanted cardiac
defibrillator device. 11 of 43 patients received appropriate
shock treatment for sustained ventricular tachycardia or
fibrillation, and ARI variability was significantly higher in
these patients compared to patients who did not develop
arrhythmia (Porter et al., 2019). In the present paper we
observed a relationship between the initial BVR and the
corresponding reduction following beta blockade. Consequently
beta-adrenergic blockade may have a greater effect on BVR
in individuals at increased arrhythmic risk compared to
those at low risk.
Clinical conditions associated with high arrhythmia risk are
commonly accompanied by adverse ventricular remodeling
with downregulation of ionic currents and dysregulation of
Ca2+handling and reduced repolarization reserve (Armoundas
et al., 2001). Beta-adrenergic stimulation in the presence
of reduced repolarization reserve (Iks block) has been
shown to dramatically increase BVR and be proarrhythmic
(Johnson et al., 2010). The importance of downregulation
of IKs in promoting excess BVR during beta-adrenergic
stimulation was further demonstrated in a study identifying
a role of calcium mediated mechanisms in the generation
of arrhythmias (Johnson et al., 2013). In a recent study in
the chronic AV block dog model using monophasic action
potential recordings, remodeling resulted in an increase of
low frequency oscillations of ventricular MAP duration.
Furthermore, low frequency BVR measured as beat to beat
differences of MAP duration, also increased. Increased
low frequency power was positively related to Torsades de
Pointes inducibility (Sprenkeler et al., 2019). These results
suggest an interaction between the remodeling process,
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low frequency oscillation and beat to beat variability of
ventricular repolarization as playing an important role in
arrhythmogenesis. The findings are in keeping with recent
computational modeling studies involving phasic low frequency
beta-adrenergic and mechanical stimulation. When remodeling
was simulated by reducing repolarization reserve (reduced Ikr)
and incorporating calcium overload early after depolarizations
and triggered activity were readily induced (Pueyo et al., 2016b;
Sampedro-Puente et al., 2019).
While a number of studies have investigated the cellular
mechanisms underlying modulation of BVR by beta-adrenergic
stimulation and the consequent effect on arrhythmia initiation
(Johnson et al., 2010, 2013; Szentandrássy et al., 2015),
only a few have so far examined mechanisms underlying
low frequency oscillation of ventricular APD (Pueyo et al.,
2016b; Sampedro-Puente et al., 2019). Regarding BVR ion
channel stochasticity and calcium cyclical variation have
both been identified as major contributors. Regarding low
frequency oscillations of ventricular APD a direct action
of beta-adrenergic stimulation and mechano-electric feedback
has been suggested.
Recent computational research has shown that the major ionic
contributors to inter-individual differences in LF oscillations
of APD and beat-to-beat APD variability are IKr, ICaL, and
IK1 (Sampedro-Puente et al., 2019). In this study, a set
of stochastic human ventricular action potential models was
developed by individually varying the ionic conductances of
IKr, ICaL, and IK1 from their nominal values in the O’Hara-
Virág-Varró-Rudy (ORd) action potential model (O’Hara et al.,
2011). Beta-adrenergic and mechanical stretch effects were
included in the models to simulate sympathetic modulation
of ventricular electrophysiology at the cell level (Pueyo et al.,
2016b; Sampedro-Puente et al., 2019). For each of the simulated
models, normalized measures of LF oscillation magnitude of
APD (nmLF) and beat-to-beat APD variability (STV-APD)
were computed before and after beta-adrenergic blockade. In
accordance with the clinical observations of this study, beta-
adrenergic blockade in these simulated cells led to a remarkable
reduction in nmLF and also in STV-APD. Importantly, these
simulations showed a wide range of nmLF and STV-APD
initial values as well as of their changes in response to beta-
adrenergic blockade. In line with the presented clinical data,
higher nmLF and STV-APD initial values were associated
with larger beta-adrenergic blockade-induced decreases in the
magnitudes of both markers. A strong correlation was observed
between the effects of beta-adrenergic blockade on nmLF
and STV-APD.
The reduction in nmLF in response to beta-adrenergic
blockade, which could be observed to a greater or lesser extent
in all the virtual cells, can be explained on the basis of beta-
adrenergic stimulation enhancing LF oscillations of APD via
differential phosphorylation and dephosphorylation kinetics of
cellular PKA targets (mainly ICaL and IKs) (Pueyo et al., 2016b;
Sampedro-Puente et al., 2019). For STV-APD, the reduction
induced by beta-adrenergic blockade is justified by the fact that
beta-adrenergic stimulation modulates, on the one hand, the
LF oscillations of APD and, on the other hand, the stochastic
gating of ionic currents active during the repolarization phase
(Sampedro-Puente et al., 2019).
Mechanoelectric feedback (MEF) has been suggested to
contribute to the development of LF oscillations and BVR of APD
in humans in vivo (Hanson et al., 2014) and by computational
simulation, these adrenergic and mechanical actions have been
shown to synergistically potentiate the oscillatory behavior
and temporal variability of cellular ventricular repolarization
(Pueyo et al., 2016b; Sampedro-Puente et al., 2019), in accord
with the well-known potentiation of MEF effects by beta-
adrenergic stimulation (Horner et al., 1996; Puglisi et al.,
2013). The role of MEF, possibly through stretch-activated
channels, in contributing to BVR is supported by experimental
evidence in the chronic atrioventricular-block dog model, where
beat-to-beat preload changes have been shown to increase
short-term variability of monophasic APD (Stams et al.,
2016). The timing of electro-mechanical coupling may also
be important. In a canine model IKs block prolonged APD
altering the timing of ventricular repolarization in relation
to the ventricular pressure curve. Under these conditions the
addition of left stellate stimulation induced Torsades de Points
(ter Bekke et al., 2019).
The importance of risk stratification for arrhythmia and
sudden death to guide patient selection for ICD implantation
has already been stressed. A number of non-invasive markers
of risk have been proposed including amongst others heart rate
variability, baroreflex sensitivity, microvolt T-wave alternans,
heart rate turbulence, Tpeak-Tend as an index of dispersion
of repolarization and QT interval variability, all of which are
modulated by autonomic activity (Baumert et al., 2016; Priori
et al., 2016; Tse et al., 2017). However, despite showing promise
none of these has so far influenced clinical practice. Numerous
studies have examined the predictive power of BVR estimated
in humans as QT variability or intracardiac QT interval as have
been comprehensively summarized by Baumert et al. (2016).
While many studies showed encouraging results a significant
number were less so. It was concluded by these authors
that analysis of joint RR and QT dynamics seems to allow
detecting repolarization stability preceding malignant ventricular
arrhythmias in patients post MI, and prospective studies are
needed on the predictive value of QTV as part of a multivariate
risk stratification procedure in different well-defined populations.
The variable that has shown the most consistent association
with sudden cardiac death is reduced left ventricular ejection
fraction and remains the gold standard for risk stratification
of patients with ischemic heart disease and primary prevention
(Priori et al., 2016). A conceptually attractive aspect of the
application of BVR is that experimental work in a canine
complete AV block model indicates that the strong association
with inducible TdP/VF reflects ventricular remodeling which is
a characteristic feature of at-risk patients (Smoczynska et al.,
2019). A recent multicenter prospective clinical trial involving 44
centers in 15 EU countries now provides convincing evidence for
enhanced low frequency oscillations of ventricular repolarization,
measured from the ECG T-wave vector referred to as Periodic
Repolarization Dynamics (PRD), to be one of the strongest
predictors of ventricular arrhythmia and sudden death in post MI
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patients (Bauer et al., 2019). Comparison of the potential clinical
value of each of these various biomarkers is hindered by the fact
that most studies have focused on just one or a small number
of these parameters and the lack of any standardization of
methodology and study population. Future research should focus
on evaluating the prognostic value of possible combinations of
these biomarkers in prospective multivariate analysis in specific
patient populations.
Limitations
The study population were patients with ostensibly normal
ventricles undergoing routine ablation procedures for
supraventricular arrhythmias. Eight of the 12 patients had
persistent atrial fibrillation and therefore the possibility of
some ventricular remodeling cannot be excluded. However,
the routine procedure for atrial fibrillation ablation involves
transseptal puncture to allow access to the left atrium from
the right atrium. This enables placement of an LV decapolar
catheter for the research procedure (right atrium to left atrium
to left ventricle via the mitral valve) without the need for
arterial puncture for retrograde access to the left ventricle. In
many years experience of acquiring basic electrophysiological
data from the in vivo human heart in order to complement
laboratory studies, we have always considered it a priority
to integrate the research protocol with the clinical protocol
avoiding additional invasive procedures. We recognize that
it would be ideal to have longer recordings when studying
LF related parameters, but to comply with clinical studies we
designed the study with view to limiting the duration of the study
as much as possible.
Recordings were made from 20 localized right and left
ventricular endocardial sites and then averaged. It is possible that
other regions may have yielded different results. Furthermore,
averaging may confound local beat-to-beat variabilities, although
we did not find evidence for this when comparing the STV
reduction across electrode sites and between left and right
ventricle. In addition, breathing frequency may also play a role.
In this work we report averaged data from two different breathing
frequencies (15 and 30 breaths/min), but the reduction in ARI
STV between the two breathing frequencies was not found to be
significantly different.
Clinical Implications
Understanding the mechanisms underlying the interaction
between beta-adrenergic stimulation, the LF oscillatory behavior
of APD and beat-to-beat APD variability is important for the
development of therapeutic strategies for the prevention of
arrhythmia and sudden cardiac death. Enhanced oscillations
of ventricular repolarization in the LF range measured
from the ECG T-wave vector and referred to as periodic
repolarization dynamics (PRD) have emerged as one of the
strongest predictors of arrhythmia and sudden cardiac death
in cardiac patients and are the subject of ongoing clinical
trials (Rizas et al., 2014, 2016, 2017, 2019; Hamm et al.,
2017; Bauer et al., 2019). The present work identifies several
specific features of the interaction between beta-adrenergic
stimulation, the LF oscillatory behavior of APD and beat-to-
beat APD variability that are reproducible by computational
modeling which enables mechanistic insight to be gained at
the cellular level.
CONCLUSION
In patients with normal ventricles acute beta-adrenergic
blockade modulated LF oscillatory behavior of ventricular APD
(measured as ARIs) and beat-to-beat variability of APD in
a manner that was dependent on baseline APD variability.
A strong correlation was present between the effect of beta-
adrenergic blockade on LF oscillation of APD and beat-
to-beat variability of APD. These findings are discussed
in relation to computational modeling which reproduced
the clinical findings and investigated cellular mechanisms.
These observations provide valuable insight into the strong
association of LF oscillations of ventricular repolarization
and arrhythmic and sudden cardiac death. Further work is
warranted to improve our understanding in order to develop
therapeutic strategies.
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